Tuesday, July 13, 2021 2:49:47 PM
You have a really tough time doing some critical thinking ehhh?
Where do you think the money for LAHO came from?
The only reason they are making this move is to save face to the investing public. They messed up big time in their huge dilution operation at LAHO while pumping a merger with GSCG. Now they decide they will payout shareholders a small piece of the pie that they acquired from selling tons of shares in LAHO before it got delisted. This will in turn cause more buying pressure on their new merger play here at MSSV. It will create a great storyline where a delisted OTC ticker made an unprecedented move by paying out its shareholders that were taken to delisting and left holding bags. This will give great credibility to this reverse merger and the managers in charge.
Disappointing I have to explain this simple scenario that is playing out like a well tuned guitar.
Where do you think the money for LAHO came from?
The only reason they are making this move is to save face to the investing public. They messed up big time in their huge dilution operation at LAHO while pumping a merger with GSCG. Now they decide they will payout shareholders a small piece of the pie that they acquired from selling tons of shares in LAHO before it got delisted. This will in turn cause more buying pressure on their new merger play here at MSSV. It will create a great storyline where a delisted OTC ticker made an unprecedented move by paying out its shareholders that were taken to delisting and left holding bags. This will give great credibility to this reverse merger and the managers in charge.
Disappointing I have to explain this simple scenario that is playing out like a well tuned guitar.
Recent RMTG News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 03:48:57 PM
- RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind • ACCESS Newswire • 03/26/2026 11:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:12:56 PM
- RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit • ACCESS Newswire • 11/18/2025 12:59:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:59:17 PM
- RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership • ACCESS Newswire • 10/21/2025 11:59:00 AM
- RMTG Expands into Brazil with Strategic Representation Agreement • ACCESS Newswire • 10/14/2025 11:59:00 AM
- RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries • ACCESS Newswire • 10/08/2025 11:59:00 AM
- RMTG Partners with BKFC as Official Regenerative Medicine Provider • ACCESS Newswire • 09/29/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:32:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2025 08:06:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/30/2025 04:15:10 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/12/2025 01:56:55 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/14/2025 08:33:15 PM
